Light Chain Amyloidosis
📧 Sign up to get email alerts when something new happens for Light Chain Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis [Phase 2]
Phase 2 trial evaluating daratumumab with bortezomib and dexamethasone for systemic light chain amyloidosis (AL) in Mayo 04 Stage III.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis [Phase 1]
Phase 1 trial update of oral ixazomib in adults with relapsed or refractory light chain amyloidosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating high-dose melphalan with autologous stem cell transplantation in patients with light chain amyloidosis h…